NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Total Assets (Quarterly): 168.87M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 168.87M |
| September 30, 2023 | 192.15M |
| June 30, 2023 | 220.54M |
| March 31, 2023 | 258.84M |
| December 31, 2022 | 307.40M |
| September 30, 2022 | 335.87M |
| June 30, 2022 | 337.37M |
| March 31, 2022 | 359.77M |
| December 31, 2021 | 402.39M |
| September 30, 2021 | 415.86M |
| June 30, 2021 | 423.01M |
| March 31, 2021 | 445.54M |
| Date | Value |
|---|---|
| December 31, 2020 | 329.04M |
| September 30, 2020 | 326.08M |
| June 30, 2020 | 347.28M |
| March 31, 2020 | 360.70M |
| December 31, 2019 | 380.40M |
| September 30, 2019 | 390.62M |
| June 30, 2019 | 396.70M |
| March 31, 2019 | 231.63M |
| December 31, 2018 | 246.08M |
| June 30, 2018 | 237.56M |
| December 31, 2017 | 248.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
168.87M
Minimum
Dec 2023
445.54M
Maximum
Mar 2021
336.76M
Average
347.28M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Catalent Inc | 9.879B |
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 89.82M |
| Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.23M |
| Shareholders Equity (Quarterly) | 148.64M |
| Current Ratio | 7.791 |